Y-90 Resin Microspheres: FDA Approval Broadens Therapeutic Scope in Unresectable HCC

Y-90 microspheres gain FDA approval: Unresectable HCC shows 98.5% response, 100% local control, and 300+ days duration of response.

Prof. Dr. Mustafa Özdoğan
Y-90 Resin Microspheres: FDA Approval Broadens Therapeutic Scope in Unresectable HCC